1) High-Dose Therapy for the Treatment of Primary Systemic Amyloidosis
R.L. Comenzo, Hematology 1999, 11 pages

Download (comenzo.pdf) 75K

2) Amyloidosis: Recognition, Prognosis, and Conventional Therapy Morie
A. Gertz, Hematology 1999, 9 pages

Download (gertz.pdf) 183K

3) Amyloidosis and the respiratory tract
Julian D Gillmore, Philip N Hawkins, 8 pages

Download (1.pdf) 242K

4) Dose-Intensive Melphalan With Blood Stem-Cell Support for the Treatment of AL (Amyloid Light-Chain) Amyloidosis: Survival and Responses in 25 Patients
Raymond L. Comenzo, Evan Vosburgh, Rodney H. Falk, Vaishali Sanchorawala, Johann Reisinger, Simon Dubrey, Laura M. Dember, John L. Berk, Gorgun Akpek, Michael LaValley, Carl O’Hara, Charles F. Arkin, Daniel G. Wright, and Martha Skinner, May 1998, 9 pages.

Download (2.pdf) 125K

5) Treatment of AL Amyloidosis with 48-Iodo-48-Deoxydoxorubicin (IDOX): An Update
Giampaolo Merlini, et al., February 1999, 1 page.

Download (3.pdf) 39K

6) Long-Term Survival (10 Years or More) in 30 Patients With Primary Amyloidosis
Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E. Witzig, John A. Lust, Martha Q. Lacy, and Terry M. Therneau, February 1999, Blood, 5 pages.

Download (4.pdf) 70K

7) Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: A Status Report - Bone Marrow Transplantation (2000) 25, 465–470
MA Gertz, MQ Lacy and A Dispenzieri
Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA

Download (5.pdf) 60K

8) Prospective Randomized Trial of Melphalan and Prednisone Versus Vincristine, Carmustine, Melphalan, Cyclophosphamide, and Prednisone in the Treatment of Primary Systemic Amyloidosis Journal of Clinical Oncology, Vol 17, No 1 (January), 1999: pp 262-267
Morie A. Gertz, Martha Q. Lacy, John A. Lust, Philip R. Greipp, Thomas E. Witzig, and Robert A. Kyle

Download (mayotrl.pdf) 45K